Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
The use of enzyme inhibitors to clarify the role of thromboxane A2 in vasoocclusive disease has been complicated by their non-specific action. To address this problem we have examined the effects of thromboxane A2/prostaglandin endoperoxide receptor antagonism in a canine model of platelet-dependent...
Сохранить в:
| Опубликовано в:: | J Clin Invest |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
1986
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC423371/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3003161/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI112329 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
